Browse studies

Find your next paid study

407 recruiting studies matching your filters

Hearing Loss and Brain Health Study

Hearing loss is a prevalent and modifiable risk factor for cognitive decline and dementia in older adults, yet access to hearing care remains limited. Over-the…

Hearing Loss, Adult-OnsetDementia

Estimated

~$10 – $6,250

University of Southern CaliforniaNCT07288463

Observational

Effects of Hip Bump Manipulation Versus Sham Treatment on Hip Internal Rotation, External Rotator Strength, and Bipodal Landing in Healthy Adults Aged 18-45: A Single-Blinded Randomized Controlled Trial

The purpose of this study is to objectively assess the effects of hip bump manipulation (HBM) on a healthy population aged 18-45 years. We hypothesize that the…

Assessment of Hip Strength, Range of Motion, EMG Activation, and Landing Mechanics in Healthy SubjectsHealthy Adult Subjects

Estimated

~$10 – $6,250

Dominican University New YorkNCT07025434

Phase 2

Phase II Study of Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant in T-Cell Lymphoma

This phase II trial tests how well ruxolitinib as a maintenance medication works to prevent relapse and graft-versus-host disease (GVHD) for patients who have …

T-cell LymphomaGraft Versus Host DiseaseLymphoma, T-Cell+5 more

Estimated

~$10 – $7,500

Jonathan BrammerNCT07356245

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients With Abdominal and Pelvic Tumors Undergoing Therapy

This clinical trial studies how well 3-dimensional multi-parametric ultrasound (3D MPUS) imaging works as a decision-support tool for patients with liver tumor…

Liver Cancer, Adult

Estimated

~$10 – $750

University of California, San DiegoNCT05705219

Phase 1

A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated Tmod™ CAR T, in Heterozygous HLA-A02 Adults With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express EGFR and Have Lost HLA-A02 Expression

The goal of this study is to test A2B395, an allogeneic logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorectal cancer (CRC), n…

Solid Tumor, AdultColorectal CancerNon-Small Cell Lung+14 more

Estimated

~$10 – $8,750

A2 Biotherapeutics Inc.NCT06682793

Observational

Organization and Development of Motor Cortical Circuits for Speech Production in Stuttering

The overall objective of this study is to examine inter effector areas (IEAs) activity and functional connectivity during continuous speech production in stutt…

StutterStuttering, AdultStuttering+1 more

Estimated

~$10 – $6,250

University of MichiganNCT07180628

Myasthenia Gravis Foundation of America Global MG Patient Registry

The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States. The main questions it…

Myasthaenia GravisMyastheniaMyasthenia Gravis Associated with Thymoma+10 more

Estimated

~$10 – $750

Myasthenia Gravis Foundation of AmericaNCT06617741

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

There are no guidelines or prospective studies defining the optimal surgical treatment for gliomas of older patients (≥70 years) or those with limited function…

GlioblastomaGlioblastoma, IDH-wildtypeGlioblastoma Multiforme+2 more

Estimated

~$10 – $1,125

Jasper GerritsenNCT06146725

Molecular Services and EMR-Laboratory Integration Application (ELIA) for Reducing Leakage and Improving Healthcare Disparities in Cancer Patients

The goal of this observational study is to measure and try to reduce leakage in precision medicine care in the community cancer clinic. The goal of precision m…

Advanced CancerSolid Tumor, AdultMyeloid Malignancy

Estimated

~$10 – $1,125

Bien-Willner Physicians Group PANCT06090513

Observational

Kaempferol Absorption and Pharmacokinetics Evaluation (K.A.P.E.)

This study is a multi-site clinical trial designed to evaluate how the body absorbs and processes Kaempferol, a naturally occurring compound found in many plan…

No DiseaseMitochondria HealthLongevity+2 more

Estimated

~$10 – $6,250

University of PittsburghNCT07322406

Phase 1

A Phase 1 Study of the Safety and Efficacy of CRX100 as Monotherapy and in Combination With Pembrolizumab in Advanced Solid Malignancies

This clinical study is an open-label, Phase 1, dose-escalation study to determine the safety, tolerability, and efficacy of the drug product produced by Admini…

Solid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more

Estimated

~$10 – $8,750

BioEclipse TherapeuticsNCT04282044

Phase 1

A Phase 1/2 Open Label, Multicenter, Dose Escalation and Expansion Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

The main purpose of this study is to identify a safe and potentially effective dose of tuspetinib to be used in future studies in study participants diagnosed …

Leukemia, Myeloid, AcuteRefractory AMLRelapsed Adult AML+2 more

Estimated

~$10 – $8,750

Aptose Biosciences Inc.NCT03850574

Hearing Loss and Brain Health Study

Effects of Hip Bump Manipulation Versus Sham Treatment on Hip Internal Rotation, External Rotator Strength, and Bipodal Landing in Healthy Adults Aged 18-45: A Single-Blinded Randomized Controlled Trial

Phase II Study of Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant in T-Cell Lymphoma

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients With Abdominal and Pelvic Tumors Undergoing Therapy

A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated Tmod™ CAR T, in Heterozygous HLA-A*02 Adults With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Organization and Development of Motor Cortical Circuits for Speech Production in Stuttering

Myasthenia Gravis Foundation of America Global MG Patient Registry

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

Molecular Services and EMR-Laboratory Integration Application (ELIA) for Reducing Leakage and Improving Healthcare Disparities in Cancer Patients

Kaempferol Absorption and Pharmacokinetics Evaluation (K.A.P.E.)

A Phase 1 Study of the Safety and Efficacy of CRX100 as Monotherapy and in Combination With Pembrolizumab in Advanced Solid Malignancies

A Phase 1/2 Open Label, Multicenter, Dose Escalation and Expansion Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated Tmod™ CAR T, in Heterozygous HLA-A02 Adults With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express EGFR and Have Lost HLA-A02 Expression